Financial insights of LSH

MyFinsight

For the quarter ending 2025-09-30, LSH made $6,099,889 in revenue. -$1,320,288 in net income. Net profit margin of -21.64%.

Unit: Dollar

Income Statement	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Total revenue	6,099,889	3,803,140	3,595,589	4,081,554
Cross Border Freight Solutions-Nonrelated Party	3,733,846	-	-	-
Cross Border Freight Solutions-Related Party	466,506	-	-	-
Nonrelated Party-Pharmaceutical Products	790,770	-	-	-
Total cost of revenue	4,991,122	3,087,289	3,637,820	3,559,015
Gross profit	1,108,767	715,851	-42,231	522,539
Selling expenses	189,411	103,630	54,488	-
General and administrative expenses	2,107,655	1,680,339	1,911,853	1,837,206
Provision of allowance for expected credit loss	83,325	6,065	-10,881	12,837
Total operating expenses	2,380,391	1,790,034	1,955,460	1,850,043
Loss from operations	-1,271,624	-1,074,183	-1,997,691	-1,327,504
Other income, net	146,839	109,255	91,753	109,788
Interest expense	196,441	87,274	40,882	28,110
Total other (expense) income	-49,602	21,981	50,871	81,678
Loss before income taxes	-1,321,226	-1,052,202	-1,946,820	-1,245,826
Income tax expense	35,990	18,594	0	89,581
Net (loss) income	-	-1,070,796	-1,946,820	-1,335,407
Net loss	-1,357,216	-1,070,796	-1,946,820	-1,335,407
Foreign currency translation gain	36,928	-	-	-
Comprehensive loss	-1,320,288	-	-	-

Loss per share basic (in dollars per share)	-0.09	-0.14	-0.26	-0.18
Loss per share diluted (in dollars per share)	-0.09	-0.14	-0.26	-0.18
Weighted average shares outstanding basic (in shares)	14,733,489	7,500,000	7,500,000	7,500,000
Weighted average shares outstanding diluted (in shares)	14,733,489	7,500,000	7,500,000	7,500,000